Bayer Investor News | Bayer Global

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

1 - 10of 446 News

1 - 10of 446 News

November 12, 2025

Business figures for the third quarter:

Bayer confirms 2025 Group outlook, progresses on strategic priorities

November 06, 2025

Dr. Judith Hartmann to become new Chief Financial Officer of Bayer AG

November 06, 2025

Not intended for U.S. and UK Media – Late-Breaking data from FINE-ONE Phase III study presented at ASN Kidney Week 2025

Finerenone showed statistically significant reduction of UACR in adults with chronic kidney disease associated with type 1 diabetes

October 30, 2025

PCB litigation: Washington Supreme Court ruling in Erickson

October 24, 2025

Not intended for U.S. and UK Media

Bayer’s Lynkuet™ (elinzanetant) approved in the U.S. for treatment of moderate to severe vasomotor symptoms due to menopause

September 22, 2025

Not intended for US and UK Media

Bayer first company to advance cell therapy as well as gene therapy against Parkinson’s disease

September 18, 2025

Not intended for U.S. and UK Media

New drug application for gadoquatrane accepted for review in China

August 30, 2025

Not intended for U.S. and UK Media

Data from Phase III VICTOR clinical trial of vericiguat presented at ESC Congress 2025

August 18, 2025

Monsanto reaches agreements in principle to resolve additional PCB cases at the Sky Valley Education Center

August 06, 2025

Bayer posts positive second quarter and progress on strategic priorities

Inform Yourself on Special Topics

Control Weeds Not Farming

Control Weeds, Not Farming

Farmers discussing their weed management

Everything You Need to Know About Glyphosate

some-bayer-group-headquarters

Managing Glyphosate Litigation

woman harvesting carrots

Managing and Mitigating PCB Litigation Risk